Tirzepatide is a modified 39-amino-acid peptide commonly studied in laboratory settings for its interaction with glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor pathways. These receptor systems are central to incretin biology and are frequently examined in metabolic research.

In research environments, tirzepatide is often examined for how dual-receptor incretin compounds may affect biological systems involved in glucose regulation, insulin response, appetite-related signaling, gastric-emptying models, energy expenditure, and weight loss research.

Its research relevance also extends to obesity-related models, cardiometabolic signaling, adipose tissue research, nutrient partitioning, and metabolic flexibility. Compared with single-receptor incretin models, tirzepatide is studied for the way dual GIP/GLP-1 activation may influence multiple metabolic pathways at once.

At Vistara Labs, Tirzepatide 10mg and 20mg are supplied strictly for research use only and are intended for qualified laboratory, analytical, or educational research applications. They are not intended for human or veterinary use.

Key Research Areas

• Incretin and metabolic signaling research
• GLP-1 and GIP receptor pathway studies
• Glucose homeostasis and insulin-response research
• Appetite-regulation and energy-balance models
• Obesity-related and body composition research
• Cardiometabolic and nutrient-partitioning studies
• Adipose tissue and metabolic flexibility research

Product Info

Product name: Tirzepatide
Amount: 10mg or 20mg per vial
Molecular formula: C225H348N48O68
Molecular weight: 4813 g/mol
Sequence: Modified 39-amino-acid peptide
Purity: 99%+
Research use: For research use only, not for human or veterinary use